219 related articles for article (PubMed ID: 7879135)
1. Renal transplant graft survival results and HLA-A,B, DR mismatching.
Cicciarelli J; Iwaki Y; McCalmon R; Thompson J
Transplant Proc; 1995 Feb; 27(1):660-3. PubMed ID: 7879135
[No Abstract] [Full Text] [Related]
2. Influence of HLA antigens of renal transplant recipients on graft survival.
Alamartine E; Berthoux F; Acquart S; Lepetit JC
Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
[No Abstract] [Full Text] [Related]
3. Repeated HLA mismatches increase the failure rate of second kidney transplants. Collaborative Transplant Study.
Opelz G
Transplant Proc; 1995 Feb; 27(1):658-9. PubMed ID: 7879134
[No Abstract] [Full Text] [Related]
4. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant.
Leivestad T; Berger L; Thorsby E
Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824
[No Abstract] [Full Text] [Related]
5. Effect of HLA matching on graft survival in live donor kidney transplantations.
Velidedeoğlu E; Bilgin N; Haberal M
Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491
[No Abstract] [Full Text] [Related]
6. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing.
Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E
Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277
[No Abstract] [Full Text] [Related]
7. Critical importance of HLA antigen matching in cadaveric kidney transplantation with high overall survival rates. The Manchester UK Kidney Transplant Team.
Dyer PA; Martin S; Johnson RW
Transplant Proc; 1992 Dec; 24(6):2454. PubMed ID: 1465827
[No Abstract] [Full Text] [Related]
8. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
[No Abstract] [Full Text] [Related]
9. Beneficial HLA matching: its phase of impact on graft survival.
Gilks WR; Bradley BA; Gore SM
Transplant Proc; 1987 Feb; 19(1 Pt 1):664-5. PubMed ID: 3274833
[No Abstract] [Full Text] [Related]
10. Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.
Doxiadis II; Smits JM; Stobbe I; Schreuder GM; Persijn GG; van Houwelingen H; van Rood JJ; Claas FH
Transplant Proc; 1996 Feb; 28(1):224. PubMed ID: 8644189
[No Abstract] [Full Text] [Related]
11. HLA compatibility can be predicted by matching only three residues with outward oriented sidechains.
Takemoto S; Terasaki PI
Transplant Proc; 1996 Jun; 28(3):1264-6. PubMed ID: 8658652
[TBL] [Abstract][Full Text] [Related]
12. Organ shortage and a long waiting list allow local kidney allocation to insure both short ischemia time and good HLA-A, B, DR matching.
Mosca F; Bertoni E; Tosi P; Bandini S; Rosati A; Pradella F; Mattiuz P; Taddei G; Nicita G; Rindi P
Transplant Proc; 1995 Oct; 27(5):2695-6. PubMed ID: 7482878
[No Abstract] [Full Text] [Related]
13. Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors.
Thorogood J; Doxiadis II; Schreuder GM; Persijn GG; van Rood JJ
Transplant Proc; 1993 Dec; 25(6):3051-2. PubMed ID: 8266449
[No Abstract] [Full Text] [Related]
14. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
Martin S; Connolly J; Jos V
Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
[No Abstract] [Full Text] [Related]
15. The relevance of HLA A,B,C, matching on graft survival, patient survival, and graft function in living related renal transplant patients treated with cyclosporine.
Masri MA; Dhawan IK; Hayes K; Zahir M; Shanwaz M; Shakuntala S; Pingle A
Transplant Proc; 1992 Oct; 24(5):1676-7. PubMed ID: 1412793
[No Abstract] [Full Text] [Related]
16. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
[No Abstract] [Full Text] [Related]
17. Arguments against HLA-A, -B, -DR mismatching in kidney transplant recipients.
Cicciarelli J; Terasaki P
Transplant Proc; 1989 Feb; 21(1 Pt 1):659-60. PubMed ID: 2650213
[No Abstract] [Full Text] [Related]
18. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
Cicciarelli J; Terasaki PI; Cecka M; Mickey MR
Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831
[No Abstract] [Full Text] [Related]
19. Effect on sensitisation of giving HLA-DR-matched blood to potential renal transplant recipients.
Middleton D; Martin J; Magee BA; Douglas JF
Transplant Proc; 1992 Dec; 24(6):2535-6. PubMed ID: 1465857
[No Abstract] [Full Text] [Related]
20. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses.
Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W
Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
